Text
The investment signals a significant advancement in developing innovative treatments for women's reproductive health issues.
Ferring Pharmaceuticals and PharmaBiome announced a comprehensive research and development collaboration today.
A recent study analyzed microbial colonization in people with RAG deficiency to shed light on the effects of secondary immunodeficiencies.
Results from a recent study suggest a correlation between the diversity and composition of the gut microbiota prior to transplantation and both the patient's survival and the probability of developing…
The findings of a recent study suggest that a mixture of B. infantis and HMOs can modulate the gut microbiota in adults.
The findings of a recent study suggest that resistant-starch supplements can alter the gut microbiota in ways that alleviate NAFLD.
In a significant move to expand its immuno-oncology portfolio, Boehringer Ingelheim has acquired T3 Pharmaceuticals AG, a Swiss biotech company specializing in bacterial cancer therapy.
Epatrex, a new nutraceutical compound formulated as a three-layer tablet containing the probiotic Lactobacillus casei LC-XCAL.
Microbial differences may help to identify targets that could be modulated to mitigate health inequities.
The interplay between micronutrients and the microbiome is a significant factor in determining the risk of vitamin and mineral deficiencies, which has implications for global public health.
